Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

2.3K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
2.3K
Fibril-associated Collagen01:11

Fibril-associated Collagen

2.6K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
2.6K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

171
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
171
Human Genetics01:28

Human Genetics

698
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
698
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutraceutical Applications of <i>Withania somnifera</i>: The Scientific Knowledge for Rational Modern Use of the "Ayurvedic Adaptogen".

Foods (Basel, Switzerland)·2026
Same author

Expanding the landscape of tRNA pathogenic variants in mitochondrial DNA.

Brain communications·2026
Same author

Reducing Body Myopathy in Female Patients With <i>FHL1</i> Variants Showing Rapid and Severe Evolution Mimicking Inflammatory Myopathy: A Case Series.

Neurology. Genetics·2026
Same author

Letter to the Editor: Gastrointestinal Pseudo-Obstruction Is Not an Uncommon Phenotypic Manifestation of POLG1 Variants-Authors' Reply.

European journal of neurology·2026
Same author

Protective Effects of <i>Myrtus communis</i> Essential Oil Against Bisphenol A-Induced Sperm Dysfunction: Insights from Lipidomic, Amino Acid Profiling, Oxidative Stress and Molecular Docking.

Antioxidants (Basel, Switzerland)·2026
Same author

Ziziphus budhensis Seed Extracts: Phytoconstituents and Preliminary In Vitro and In Vivo Biological Activities.

Chemistry & biodiversity·2026

Related Experiment Video

Updated: Sep 2, 2025

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.9K

Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction.

Ilaria Gregorio1, Maddalena Mereu2,3, Gabriella Contarini2,3

  • 1Department of Molecular Medicine, University of Padova, 35131 Padova, Italy.

Disease Models & Mechanisms
|August 10, 2022
PubMed
Summary

Collagen VI (COL6) deficiency impairs brain function, causing deficits in sensorimotor gating and attention. This study reveals COL6

Keywords:
Central nervous systemCognitive functionCollagen VIDopamineMouse modelPrefrontal cortex

More Related Videos

Assessment of Social Interaction Behaviors
06:41

Assessment of Social Interaction Behaviors

Published on: February 25, 2011

93.7K
Dissection and Culture of Mouse Dopaminergic and Striatal Explants in Three-Dimensional Collagen Matrix Assays
08:24

Dissection and Culture of Mouse Dopaminergic and Striatal Explants in Three-Dimensional Collagen Matrix Assays

Published on: March 23, 2012

26.0K

Related Experiment Videos

Last Updated: Sep 2, 2025

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.9K
Assessment of Social Interaction Behaviors
06:41

Assessment of Social Interaction Behaviors

Published on: February 25, 2011

93.7K
Dissection and Culture of Mouse Dopaminergic and Striatal Explants in Three-Dimensional Collagen Matrix Assays
08:24

Dissection and Culture of Mouse Dopaminergic and Striatal Explants in Three-Dimensional Collagen Matrix Assays

Published on: March 23, 2012

26.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in collagen VI (COL6) genes cause muscle disorders like Ullrich congenital muscular dystrophy and Bethlem myopathy.
  • The role of COL6 in brain function remains largely unexplored despite recent links to neurological conditions.

Purpose of the Study:

  • To investigate the impact of COL6 deficiency on brain function and behavior.
  • To elucidate the mechanisms underlying COL6's role in the central nervous system.

Main Methods:

  • Behavioral characterization of COL6-null (Col6a1-/-) mice.
  • Analysis of dopaminergic signaling in mouse brains.
  • In vitro co-culture experiments with neural cells and meningeal fibroblasts.
  • Neuropsychological evaluation of patients with COL6-related myopathies.

Main Results:

  • COL6 deficiency in mice led to significant impairments in sensorimotor gating and attention/memory functions.
  • Col6a1-/- mice exhibited altered dopaminergic signaling, particularly in the prefrontal cortex.
  • In vitro studies demonstrated that COL6 ablation in meningeal cells impairs their ability to support dopaminergic differentiation.
  • Human patients with COL6 myopathies showed deficits in attentional control.

Conclusions:

  • COL6 plays a crucial, previously unrecognized role in maintaining dopamine circuitry function.
  • COL6 deficiency impacts neurobehavioral features related to dopamine signaling in both mice and humans.
  • These findings suggest a potential link between COL6-related myopathies and cognitive deficits.